Archive - September 2016

AMARILLO, TX - As I have discussed in recent Medtrade Monday articles, the DME industry is shifting away from the classic “assignment” model (i.e., the supplier bills and collects from Medicare) to the “non-assigned” model (i.e., the patient pays up-front cash to the supplier and the supplier submits a claim to Medicare on behalf of the patient). As the industry moves to the “non-assigned” model, a number of questions arise. This article addresses one of the

Device facilitates early detection of metastatic cancer cells and improves survival, study finds A small device implanted under the skin can improve breast cancer survival by catching cancer cells, slowing the development of metastatic tumors in other organs and allowing time to intervene with surgery or other therapies. These findings, reported in Cancer Research, suggest a path for identifying metastatic cancer early and intervening to improve outcomes. "This study shows that in the